Full article: Novel multi-target ligands of dopamine and serotonin

Unraveling the dynamics of dopamine release and its actions on target cells: Trends in Neurosciences

Full article: Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation

Frontiers Dopamine Receptor Subtypes, Physiology and Pharmacology: New Ligands and Concepts in Schizophrenia

Modulating the Neuromodulators: Dopamine, Serotonin, and the Endocannabinoid System: Trends in Neurosciences

Recent Advances in the Development of Sigma Receptor Ligands as Cytotoxic Agents: A Medicinal Chemistry Perspective

Novel Multitarget-Directed Ligands Aiming at Symptoms and Causes of Alzheimer's Disease

Computational approaches for the design of novel dopamine D2 and serotonin 5-HT2A receptor dual antagonist towards schizophrenia

N-(ω-(4-(2-Methoxyphenyl)piperazin-1-yl)alkyl)carboxamides as Dopamine D2 and D3 Receptor Ligands

Novel Bivalent Ligands Based on the Sumanirole Pharmacophore Reveal Dopamine D2 Receptor (D2R) Biased Agonism

PDF) Novel multi-target ligands of dopamine and serotonin receptors for the treatment of schizophrenia based on indazole and piperazine scaffolds–synthesis, biological activity, and structural evaluation

Regulation of natural killer cell activity by glucocorticoids, serotonin, dopamine, and epinephrine

The Efficiency of Multi-target Drugs: A Network Approach

Molecules, Free Full-Text